Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$35.8M Buy
278,454
+21,661
+8% +$2.54M 0.38% 43
2026
Q1
$30.9M Sell
256,793
-20,775
-7% -$2.4M 0.31% 46
2025
Q4
$29.2M Sell
277,568
-24,592
-8% -$2.31M 0.35% 50
2025
Q3
$25.4M Buy
302,160
+4,650
+2% +$383K 0.33% 48
2025
Q2
$23.6M Buy
297,510
+2,295
+0.8% +$182K 0.34% 48
2025
Q1
$26.5M Buy
+295,215
New +$27.6M 0.43% 31

Other funds holding MRK

OP Asset Management's MRK Position: Q2 2026 in Review

OP Asset Management increased its Merck (MRK) stake by 8.4% in Q2 2026, buying an estimated $2.54M and bringing the position to 278,454 shares worth $35.8M. The position accounts for 0.38% of the portfolio, ranked #43.

OP Asset Management first reported a position in MRK in Q1 2025 and has held it in 6 quarters since. 1,532 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • OP Asset Management held 278,454 shares of Merck worth $35.8M as of Q2 2026.
  • OP Asset Management bought 21,661 Merck shares in Q2 2026, an estimated $2.54M.
  • Merck made up 0.38% of OP Asset Management's portfolio in Q2 2026, its #43 holding.
  • OP Asset Management first reported a position in Merck in Q1 2025 and has held it in 6 quarters since.
  • 1,532 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on OP Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.